Literature DB >> 29934233

Association Between Hypertensive Disorders During Pregnancy and the Subsequent Risk of End-Stage Renal Disease: A Population-Based Follow-Up Study.

Li Dai1, Yue Chen2, Wen Sun3, Shiliang Liu4.   

Abstract

OBJECTIVE: To assess whether hypertensive disorders during pregnancy (HDPs) are associated with the subsequent development of end-stage renal disease (ESRD).
METHODS: The present study included 1 598 043 women who delivered in Canadian hospitals between April 1993 and March 2003. The baseline information was from the Canadian Institute for Health Information's Discharge Abstract Database. Women with chronic kidney disease, diabetes mellitus, and other specific conditions were excluded. A follow-up study was conducted through a record linkage on their hospitalizations as of the 13th month after the delivery discharge through March 31, 2013. The primary outcome of interest was subsequent hospitalization due to ESRD. Cox model was used to quantify the association between HDPs and ESRD hospitalization.
RESULTS: There occurred 9.9 and 1.7 ESRD hospitalizations per 100 000 person-years in the follow-up of HDPs and non-HDP women, respectively. An increased risk of ESRD hospitalization was observed in pregnant women with pre-eclampsia/eclampsia (adjusted hazard ratio [aHR] = 4.7, 95% CI 3.6-6.0), unspecified HDPs (aHR = 4.6, 95% CI 2.8-7.7), or gestational hypertension (aHR = 3.3, 95% CI 2.1-5.1). Caesarean delivery, preterm delivery, IUGR, and deep vein thrombosis were identified as significant correlates with the subsequent ESRD hospitalization. The risk of subsequent ESRD hospitalization appeared to be lower for women who had ≥2 deliveries compared with those who had one delivery during the study period.
CONCLUSION: Pregnancy complicated with HDPs was significantly associated with an increased risk of ESRD hospitalization in later life, and this association varied by HDP subtype and frequency of delivery. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pre-eclampsia; end-stage renal disease; follow-up; long-term effect

Mesh:

Year:  2018        PMID: 29934233     DOI: 10.1016/j.jogc.2018.01.022

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  10 in total

1.  Risk of chronic kidney disease in women with a history of preterm delivery: Tehran Lipid and Glucose Study.

Authors:  Marzieh Saei Ghare Naz; Maryam Rahmati; Fereidoun Azizi; Fahimeh Ramezani Tehrani
Journal:  J Nephrol       Date:  2021-07-03       Impact factor: 3.902

2.  Hypertensive Disorders of Pregnancy With and Without Prepregnancy Hypertension Are Associated With Incident Maternal Kidney Disease Subsequent to Delivery.

Authors:  Angela M Malek; Kelly J Hunt; Tanya N Turan; Julio Mateus; Daniel T Lackland; Anika Lucas; Dulaney A Wilson
Journal:  Hypertension       Date:  2022-02-25       Impact factor: 10.190

3.  Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study.

Authors:  Ali S Khashan; Marie Evans; Marius Kublickas; Fergus P McCarthy; Louise C Kenny; Peter Stenvinkel; Tony Fitzgerald; Karolina Kublickiene
Journal:  PLoS Med       Date:  2019-07-30       Impact factor: 11.069

Review 4.  Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy.

Authors:  Laura Benschop; Johannes J Duvekot; Jeanine E Roeters van Lennep
Journal:  Heart       Date:  2019-06-07       Impact factor: 5.994

Review 5.  Non-obstetric complications in preeclampsia.

Authors:  Katarzyna Pankiewicz; Ewa Szczerba; Tomasz Maciejewski; Anna Fijałkowska
Journal:  Prz Menopauzalny       Date:  2019-06-14

6.  Symptoms of Discomfort and Problems Associated with Mode of Delivery During the Puerperium: An Observational Study.

Authors:  Juan Miguel Martínez-Galiano; Miguel Delgado-Rodríguez; Julián Rodríguez-Almagro; Antonio Hernández-Martínez
Journal:  Int J Environ Res Public Health       Date:  2019-11-18       Impact factor: 3.390

7.  Stillbirth is associated with increased risk of long-term maternal renal disease: a nationwide cohort study.

Authors:  Peter M Barrett; Fergus P McCarthy; Marie Evans; Marius Kublickas; Ivan J Perry; Peter Stenvinkel; Ali S Khashan; Karolina Kublickiene
Journal:  Am J Obstet Gynecol       Date:  2020-02-26       Impact factor: 8.661

Review 8.  Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs.

Authors:  Katarzyna Pankiewicz; Anna Fijałkowska; Tadeusz Issat; Tomasz M Maciejewski
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

9.  An observational claims data analysis on the risk of maternal chronic kidney disease after preterm delivery and preeclampsia.

Authors:  Maren Goetz; Mitho Müller; Raphael Gutsfeld; Tjeerd Dijkstra; Kathrin Hassdenteufel; Sara Yvonne Brucker; Armin Bauer; Stefanie Joos; Miriam Giovanna Colombo; Sabine Hawighorst-Knapstein; Ariane Chaudhuri; Gudula Kirtschig; Frauke Saalmann; Stephanie Wallwiener
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

10.  Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype.

Authors:  Shunping Gui; Shengping Zhou; Min Liu; Yanping Zhang; Linbo Gao; Tao Wang; Rong Zhou
Journal:  Front Physiol       Date:  2021-07-13       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.